Literature DB >> 21744313

Loss of expression of DNA mismatch repair proteins in aberrant crypt foci identified in vivo by magnifying colonoscopy in subjects with hereditary nonpolyposic and sporadic colon rectal cancer.

Miguel Angel Ramírez-Ramírez1, Sergio Sobrino-Cossío, José Guillermo de la Mora-Levy, Angélica Hernández-Guerrero, Verónica de Jesús Macedo-Reyes, Héctor Aquiles Maldonado-Martínez, Juan Octavio Alonso-Larraga, Mauro Eduardo Ramírez-Solis.   

Abstract

PURPOSE: The aims of this study are to characterize the frequency, density, and distribution of aberrant crypt foci (ACF) and its histological features and to determine the frequency of loss of expression of DNA mismatch repair (MMR) proteins of subjects with hereditary nonpolyposic colorectal cancer (HNPCC) and sporadic colon rectal cancer (CRC).
METHODS: Patients with HNPCC, first-degree relatives of subjects with HNPCC, sporadic CRC, and average risk subjects of sporadic CRC were included prospectively. Total colonoscopy with chromoendoscopy using methylene blue 0.5% and magnification in the right colon (cecum and 20 cm of the ascending colon) and in the left colon (rectum) was performed; loss of expression of MLH1 and MSH2 was evaluated by immunohistochemistry in confirmed ACF.
RESULTS: Fifty-two subjects were included. Thirty-eight of the 119 ACF detected by endoscopy were biopsied. In 14 of the 38 specimens (36.8%), ACF were confirmed by histology (Cohen's kappa, 0.44). In subjects with HNPCC, ACF were identified more frequently in the right segment of the colon than in the left (73.1% vs. 26%); in contrast, ACF predominated in the left segment of the colon (89.3% vs. 10.6%) in subjects with sporadic CRC. There was a loss of MLH1 expression in ACF in subjects with HNPCC.
CONCLUSIONS: In HNPCC, we found a greater density of ACF in the right colon, and in sporadic CRC, greater density in the left. ACF present loss in the expression of DNA MMR protein and can be used as an early marker in patients with a risk of HNPCC in whom carcinogenesis appears to be accelerated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21744313     DOI: 10.1007/s12029-011-9303-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  29 in total

1.  Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis.

Authors:  M Pedroni; E Sala; A Scarselli; F Borghi; M Menigatti; P Benatti; A Percesepe; G Rossi; M Foroni; L Losi; C Di Gregorio; A De Pol; R Nascimbeni; E Di Betta; B Salerni; M P de Leon; L Roncucci
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

2.  ASGE guideline: colorectal cancer screening and surveillance.

Authors:  Raquel E Davila; Elizabeth Rajan; Todd H Baron; Douglas G Adler; James V Egan; Douglas O Faigel; Seng-Ian Gan; William K Hirota; Jonathan A Leighton; David Lichtenstein; Waqar A Qureshi; Bo Shen; Marc J Zuckerman; Trina VanGuilder; Robert D Fanelli
Journal:  Gastrointest Endosc       Date:  2006-04       Impact factor: 9.427

Review 3.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

4.  Histology of aberrant crypt foci in the human colon.

Authors:  C Di Gregorio; L Losi; R Fante; S Modica; M Ghidoni; M Pedroni; M G Tamassia; L Gafà; M Ponz de Leon; L Roncucci
Journal:  Histopathology       Date:  1997-04       Impact factor: 5.087

Review 5.  Epidemiology of colorectal cancer.

Authors:  Peter Boyle; Maria Elena Leon
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

Review 6.  Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis.

Authors:  David P Hurlstone; Simon S Cross
Journal:  J Gastroenterol Hepatol       Date:  2005-02       Impact factor: 4.029

Review 7.  Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review.

Authors:  H T Lynch; T C Smyrk; P Watson; S J Lanspa; J F Lynch; P M Lynch; R J Cavalieri; C R Boland
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

Review 8.  Aberrant crypt foci as microscopic precursors of colorectal cancer.

Authors:  Lei Cheng; Mao-De Lai
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Endoscopic identification and quantification of aberrant crypt foci in the human colon.

Authors:  Douglas G Adler; Christopher J Gostout; Darius Sorbi; Lawrence J Burgart; Linan Wang; W Scott Harmsen
Journal:  Gastrointest Endosc       Date:  2002-11       Impact factor: 9.427

10.  Aberrant crypts: putative preneoplastic foci in human colonic mucosa.

Authors:  T P Pretlow; B J Barrow; W S Ashton; M A O'Riordan; T G Pretlow; J A Jurcisek; T A Stellato
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

View more
  5 in total

1.  Colon Adenocarcinoma Stage IIA-Can We Predict Relapse?

Authors:  João Cortez Pinto; Isadora Rosa; Catarina Martins; Inês Marques; João Pereira da Silva; Ricardo Fonseca; João Freire; António Dias Pereira
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Screening of hub genes and pathways in colorectal cancer with microarray technology.

Authors:  Yonggang Wang; Tianying Zheng
Journal:  Pathol Oncol Res       Date:  2014-02-07       Impact factor: 3.201

3.  A genome-wide gene-gene interaction analysis identifies an epistatic gene pair for lung cancer susceptibility in Han Chinese.

Authors:  Minjie Chu; Ruyang Zhang; Yang Zhao; Chen Wu; Huan Guo; Baosen Zhou; Jiachun Lu; Yongyong Shi; Juncheng Dai; Guangfu Jin; Hongxia Ma; Jing Dong; Yongyue Wei; Cheng Wang; Jianhang Gong; Chongqi Sun; Meng Zhu; Yongyong Qiu; Tangchun Wu; Zhibin Hu; Dongxin Lin; Hongbing Shen; Feng Chen
Journal:  Carcinogenesis       Date:  2013-12-09       Impact factor: 4.944

4.  A pilot study comparing protein expression in different segments of the normal colon and rectum and in normal colon versus adenoma in patients with Lynch syndrome.

Authors:  Chongjuan Wei; Jinyun Chen; Mala Pande; Patrick M Lynch; Marsha L Frazier
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-21       Impact factor: 4.553

5.  A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

Authors:  Benedito Mauro Rossi; Edenir Inêz Palmero; Francisco López-Kostner; Carlos Sarroca; Carlos Alberto Vaccaro; Florencia Spirandelli; Patricia Ashton-Prolla; Yenni Rodriguez; Henrique de Campos Reis Galvão; Rui Manuel Reis; André Escremim de Paula; Luis Gustavo Capochin Romagnolo; Karin Alvarez; Adriana Della Valle; Florencia Neffa; Pablo German Kalfayan; Enrique Spirandelli; Sergio Chialina; Melva Gutiérrez Angulo; Maria Del Carmen Castro-Mujica; Julio Sanchez de Monte; Richard Quispe; Sabrina Daniela da Silva; Norma Teresa Rossi; Claudia Barletta-Carrillo; Susana Revollo; Ximena Taborga; L Lena Morillas; Hélène Tubeuf; Erika Maria Monteiro-Santos; Tamara Alejandra Piñero; Constantino Dominguez-Barrera; Patrik Wernhoff; Alexandra Martins; Eivind Hovig; Pål Møller; Mev Dominguez-Valentin
Journal:  BMC Cancer       Date:  2017-09-05       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.